Stucki A, Cordey A S, Monai N, de Flaugergues J C, Schapira M, Spertini O
Division of Haematology, University of Lausanne, Switzerland.
Lancet. 1995 Feb 4;345(8945):286-9. doi: 10.1016/s0140-6736(95)90276-7.
Involvement of the central nervous system has important therapeutic implications in acute leukaemia. Because the identification of blast cells in cerebrospinal fluid (CSF) is often difficult, there is a need for sensitive markers of leukaemic infiltration. Since the shed form of L-selectin (sL-selectin) is frequently increased in acute leukaemia (sL-selectin+ leukaemia), we examined whether assay of sL-selectin in CSF could improve our ability to detect such meningeal involvement. CSF sL-selectin was significantly (p < 0.001) higher in 15 patients with sL-selectin+ meningeal leukaemia (median 60 ng/mL, range 34-150) than in 20 patients with acute leukaemia without meningeal involvement (12 ng/mL, 1-39) or 88 control patients (14 ng/mL, 0-37). Serial measurements of sL-selectin in patients with sL-selectin+ leukaemic meningitis showed increased CSF concentrations of the cleaved receptor in 4 patients with therapy-resistant meningeal leukaemia and sustained normal concentrations in 9 patients in remission. Our results suggest that CSF sL-selectin may be a useful marker in the detection of meningeal involvement by blast cells in patients with sL-selectin+ leukaemia.
中枢神经系统受累在急性白血病中具有重要的治疗意义。由于在脑脊液(CSF)中识别原始细胞往往很困难,因此需要白血病浸润的敏感标志物。鉴于L-选择素的可溶性形式(sL-选择素)在急性白血病(sL-选择素阳性白血病)中经常升高,我们研究了检测脑脊液中的sL-选择素是否能提高我们检测此类脑膜受累的能力。15例sL-选择素阳性脑膜白血病患者的脑脊液sL-选择素水平显著更高(p<0.001)(中位数60 ng/mL,范围34 - 150),高于20例无脑膜受累的急性白血病患者(12 ng/mL,1 - 39)或88例对照患者(14 ng/mL,0 - 37)。对sL-选择素阳性白血病性脑膜炎患者进行sL-选择素的系列测量显示,4例治疗抵抗性脑膜白血病患者脑脊液中裂解受体的浓度升高,9例缓解期患者的浓度持续正常。我们的结果表明,脑脊液sL-选择素可能是检测sL-选择素阳性白血病患者脑膜原始细胞受累的有用标志物。